• PharmEdaily

Rokit Healthcare Climbs on China Patent; ECM Firms Gain [K-bio pulse]

• 김진수
• 2025.11.18
• 오전 08:20

• CellbionCEO
• OrphanDrug
• radiopharmaceutical

Cellbion CEO “We’ll Prove Orphan Drug Success...Next Month Is the Turning Point”

• 유진희
• 2025.11.17
• 오전 10:30

• PharmEdaily

Seers Rockets; DRTECH +10%, PeopleBio Rises[K-bio pulse]

• 김진수
• 2025.11.16
• 오전 09:09

• K-Bio’sLeapForward

Barriers Blocking K-Bio’s Leap Forward

• 류성
• 2025.11.14
• 오후 02:35

• Pharmedaily

PanGen Biotech Reports Q3 2025 Results, Cumulative Sales of 10.94 Billion Won

• 신민준
• 2025.11.14
• 오전 10:35

• Pharmedaily

Curious shares quadruple on first trading day…Cellumed·ABLBio shares soar[K-Bio Pulse]

• 신민준
• 2025.11.14
• 오전 08:34

• BigDeal
• K-bioPulse
• PharmEdaily

ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse]

• 김새미
• 2025.11.12
• 오후 06:05

Pharos iBio: Multiple Pharmas Reviewing License-In of PHI-101 [K-Bio Pulse]

• 임정요
• 2025.11.12
• 오전 07:42

• CelltrionHoldings
• Celltrion
• PharmEdaily

Celltrion Holdings to buy additional \338.2 billion in Celltrion

• 김새미
• 2025.11.10
• 오전 09:40

• 팜이데일리
• 젬백스앤카엘
• 지투지바이오

GV1001 Readout Nears; GemVax Surges, G2GBIO Rallies[K-Bio Pulse]

• 송영두
• 2025.11.09
• 오후 05:30